News | April 05, 2024
Dabur India expects mid-single digit revenue growth in Q4
International Business is expected to register double-digit growth in constant currency terms
International Business is expected to register double-digit growth in constant currency terms
This acquisition enables MTD to open new, strategic markets
Under the arrangement, Dr. Reddy's will have exclusive rights to promote and distribute Sanofi's vaccine brands Hexaxim, Pentaxim, Tetraxim, Menactra, FluQuadri, Adacel and Avaxim 80U
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
Cureskin aims to disrupt the large and growing skin and hair care industry in India
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
The plan is to set up an ultramodern Solvent Recovery Plant for third party purposes
he lower sales in the current quarter are mainly on account of a one?time impact on the company’s India business
These re-agent and diagnostic test kits come with 99.7% accuracy
EBITDA for Q3 FY24 almost tripled to reach Rs. 41.49 crore
Subscribe To Our Newsletter & Stay Updated
